[Comparative corrective effect of magnesium 2-pyrrolidone carboxylate and magnesium chloride on skin and hematological disorders in experimental magnesium deficiency in the rat].
D000740:Anemia / Q000188:drug therapy / Q000209:etiology*; D000818:Animals; D002712:Chlorides / Q000627:therapeutic use; D007964:Leukocytosis / Q000188:drug therapy / Q000209:etiology*; D008274:Magnesium / Q000627:therapeutic use*; D008275:Magnesium Deficiency / Q000150:complications* / Q000188:drug therapy; D008297:Male; D011761:Pyrrolidonecarboxylic Acid / Q000627:therapeutic use; D051381:Rats; D012871:Skin Diseases / Q000188:drug therapy* / Q000209:etiology
D002712:Chlorides; D008274:Magnesium; D011761:Pyrrolidonecarboxylic Acid
Effet correcteur comparé du pyrrolidone-2 carboxylate de magnésium et du chlorure de magnésium sur les troubles cutanés et hématologiques de la carence magnésique expérimentale du rat.